2009

Bornhauser, M., Oelschlaegel, U., Platzbecker, U., Bug, G., Lutterbeck, K., Kiehl, M.G., Schetelig, J., Kiani, A., Illmer, T., Schaich, M., Theuser, C., Mohr, B., Brendel, C., Fauser, A.A., Klein, S., Martin, H., Ehninger, G. & Thiede, C. (2009) Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantation. Haematologica, 94, 1613-1617.

Klein, H.U., Ruckert, C., Kohlmann, A., Bullinger, L., Thiede, C., Haferlach, T. & Dugas, M. (2009) Quantitative comparison of microarray experiments with published leukemia related gene expression signatures. BMC Bioinformatics, 10, 422.

von Bonin, M., Kiani, A., Platzbecker, U., Schetelig, J., Holig, K., Oelschlagel, U., Thiede, C., Ehninger, G. & Bornhauser, M. (2009) Third-party mesenchymal stem cells as part of the management of graft-failure after haploidentical stem cell transplantation. Leuk Res, 33, e215-217.

Mahlknecht, U., Dransfeld, C.L., Bulut, N., Kramer, M., Thiede, C., Ehninger, G. & Schaich, M. (2009) SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival. Leukemia, 23, 1929-1932.

Strunk, C.J., Platzbecker, U., Thiede, C., Schaich, M., Illmer, T., Kang, Z., Leahy, P., Li, C., Xie, X., Laughlin, M.J., Lazarus, H.M., Gerson, S.L., Bunting, K.D., Ehninger, G. & Tse, W. (2009) Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics. Am J Hematol, 84, 308-309.

von Bonin, M., Hochauf, K., Monecke, S., Radke, J., Thiede, C., Bornhauser, M., Platzbecker, U., Ehninger, G. & Illmer, T. (2009) Rhinocerebral zygomycosis and subsequent treatment decisions in a young patient with AML. Leuk Res, 33, e88-90.

Oelschlaegel, U., Mohr, B., Schaich, M., Schakel, U., Kroschinsky, F., Illmer, T., Ehninger, G. & Thiede, C. (2009) HLA-DRneg patients without acute promyelocytic leukemia show distinct immunophenotypic, genetic, molecular, and cytomorphologic characteristics compared to acute promyelocytic leukemia. Cytometry B Clin Cytom, 76, 321-327.

Schmidt-Arras, D., Bohmer, S.A., Koch, S., Muller, J.P., Blei, L., Cornils, H., Bauer, R., Korasikha, S., Thiede, C. & Bohmer, F.D. (2009) Anchoring of FLT3 in the endoplasmic reticulum alters signaling quality. Blood, 113, 3568-3576.

Verstraete, K., Koch, S., Ertugrul, S., Vandenberghe, I., Aerts, M., Vandriessche, G., Thiede, C. & Savvides, S.N. (2009) Efficient production of bioactive recombinant human Flt3 ligand in E. coli. Protein J, 28, 57-65.

Mohr, B., Oelschlaegel, U., Thiede, C., Stewart, M.M., Ehninger, G. & Platzbecker, U. (2009) The response to lenalidomide of myelodysplastic syndrome patients with deletion del(5q) can be sequentially monitored in CD34+ progenitor cells. Haematologica, 94, 430-431.

Seifert, H., Mohr, B., Thiede, C., Oelschlagel, U., Schakel, U., Illmer, T., Soucek, S., Ehninger, G. & Schaich, M. (2009) The prognostic impact of 17p (p53) deletion in 2272 adults with acute myeloid leukemia. Leukemia, 23, 656-663.

Platzbecker, U., von Bonin, M., Goekkurt, E., Radke, J., Binder, M., Kiani, A., Stoehlmacher, J., Schetelig, J., Thiede, C., Ehninger, G. & Bornhauser, M. (2009) Graft-versus-host disease prophylaxis with everolimus and tacrolimus is associated with a high incidence of sinusoidal obstruction syndrome and microangiopathy: results of the EVTAC trial. Biol Blood Marrow Transplant, 15, 101-108.

Hollink, I.H., Zwaan, C.M., Zimmermann, M., Arentsen-Peters, T.C., Pieters, R., Cloos, J., Kaspers, G.J., de Graaf, S.S., Harbott, J., Creutzig, U., Reinhardt, D., van den Heuvel-Eibrink, M.M. & Thiede, C. (2009) Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia, 23, 262-270.